Australian Court Upholds Pfizer's Lipitor Patent
On Wednesday, the Federal Court of Australia in Victoria dismissed Ranbaxy's appeal of a previous court order that enjoined the generics company from infringing a Pfizer patent for Lipitor. The court also dismissed Pfizer's appeal of a court order that revoked another underlying patent for Lipitor.
The court found that Ranbaxy's generic drug would infringe Pfizer's basic Lipitor patent...
To view the full article, register now.